Affimed Therapeutics AG, which is in the queue to make an initial public offering of its shares in the US, has in the meantime obtained $29.7 million from its venture investors and Perceptive Advisors LLC of New York City. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
